Triamcinolone Acetonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 28 USDMF, 10 CEP/COS, 5 JDMF, 6 EU WC, 22 KDMF, 26 NDC API, 1 VMF, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers, 228 FDA Orange Book, 12 Europe, 17 Canada, 2 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML, SPRAY;TOPICAL - 0.147MG/GM, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/ML, SPRAY, METERED;NASAL - 0.055MG/SPRAY, FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL, CREAM;TOPICAL - 0.025%, CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.5%, OINTMENT;TOPICAL - 0.025%, OINTMENT;TOPICAL - 0.1%, OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 9 SPI Pharma, 2 Seqens, 11 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 7 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 15 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 1 Clariant, 2 DFE Pharma, 6 Finar, 12 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 8 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 19 Roquette, 12 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Topical, 38 Thickeners and Stabilizers, 37 Solubilizers, 28 Parenteral, 28 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 18 Direct Compression, 17 Emulsifying Agents, 16 Co-Processed Excipients, 15 Coating Systems & Additives, 13 Surfactant & Foaming Agents, 10 Controlled & Modified Release, 8 Empty Capsules, 8 Granulation, 8 Taste Masking, 8 Rheology Modifiers, 6 Disintegrants & Superdisintegrants, 5 Lubricants & Glidants, 5 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

102 NEWS #PharmaBuzz

102 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 34 Finished Drug Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 2 JP, 4 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Harrow Provides TRIESENCE® Relaunch Update

20 Jun 2024

// BUSINESSWIRE

Enforcement Report - Week of October 11, 2023

11 Oct 2023

// FDA

Macleods' Generic Triamcinolone Acetonide Receives Approval in the U.S.

18 Aug 2023

// FDA

Novartis, busy with its restructuring, sells 5 eye drugs for up to $175M

15 Dec 2022

// Zoey Becker FIERCEPHARMA

Mylan's Generic Triamcinolone Acetonide Receives Approval in the U.S.

02 Nov 2022

// FDA

Enforcement Report - Week of September 21, 2022

21 Sep 2022

// FDA

Digital Content for Triamcinolone Acetonide

Triamcinolone Acetonide

Triamcinolone Acetonide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers

28 USDMF

10 CEP/COS

5 JDMF

6 EU WC

22 KDMF

26 NDC API

1 VMF

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers

228 FDA Orange Book

12 Europe

17 Canada

2 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML

SPRAY;TOPICAL - 0.147MG/GM

INJECTABLE;INJECTION - 40MG/ML

INJECTABLE;INJECTION - 80MG/ML

SPRAY, METERED;NASAL - 0.055MG/SPRAY

FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL

CREAM;TOPICAL - 0.025%

CREAM;TOPICAL - 0.1%

CREAM;TOPICAL - 0.5%

OINTMENT;TOPICAL - 0.025%

OINTMENT;TOPICAL - 0.1%

OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

9 SPI Pharma

2 Seqens

11 DKSH

1 Jai Radhe Sales

1 Pharm-RX Chemical

7 Gangwal Healthcare

12 Nanjing Well Pharmaceutical

4 ACG Worldwide

15 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

22 BASF

1 Clariant

2 DFE Pharma

6 Finar

12 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

8 Kerry

1 Kima Chemical

3 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qualicaps

19 Roquette

12 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

CREAM;TOPICAL - 0.025% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons